MedTrace Logo

Determination of Circulating Placental Biomarkers Levels to Predict the Pregnancy Outcome of First Trimester After IVF.

NCT04387994 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-08-04

No results posted yet for this study

Summary

This study will assess the predictive potential of circulating placental biomarkers for spontaneous miscarriage within the following month in an IVF setting. It is hypothesized that a robust algorithm including one or more of these biomarkers may allow for the accurate same-day distinction between women with a low and high risk of a spontaneous miscarriage.

Conditions

  • Infertility, Female
  • First Trimester Spontaneous Abortion

Interventions

OTHER

Blood samples collection

Collection of blood samples from consenting subjects to evaluate circulating biomarkers concentrations.

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Instituto Valenciano de Infertilidade de Lisboa

    lead NETWORK

Principal Investigators

  • Tetyana Semenova, MD · Instituto Valenciano de Infertilidade de Lisboa

Eligibility

Min Age
18 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-12
Primary Completion
2021-12-07
Completion
2021-12-07

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04387994 on ClinicalTrials.gov